Raywatt

Medical Devices & EquipmentSeries ASeoul, South Korea

Latest round

Series A

Last raised

Feb 2025

Total raised

$5.9M

Investors

6

About Raywatt

, operates as a medical device development company., Ltd. Raywatt develops AI-enabled catheter-based imaging diagnostic devices. The company specializes in catheter-based Optical Coherence Tomography (OCT) imaging devices for intracoronary use. These devices are designed to provide high-speed, light-based imaging for plaque characterization and stent evaluation within coronary arteries. The company also utilizes OCT data as input for machine learning algorithms to predict Fractional Flow Reserve (FFR), a measure of blood flow in coronary arteries.

Who invested in Raywatt

6 investors across 2 rounds

See all investors in Raywatt

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Feb 27, 2025

    Amount

    $4.5M

    Investors

    Locked

  2. Series A

    Dec 27, 2024

    Amount

    $1.4M

    Investors

    Locked

Questions about Raywatt

Who invested in Raywatt?

Raywatt has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Raywatt raised?

Raywatt has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Raywatt last raise money?

Raywatt's most recent round on record is a Series A, in Feb 2025.

What does Raywatt do?

, operates as a medical device development company.

Where is Raywatt headquartered?

Raywatt is headquartered in Seoul, South Korea.

Which VCs invest in companies like Raywatt?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Raywatt's stage. Their profiles are linked below.

Raising like Raywatt? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.